Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 2015-01, Vol.107 (1), p.378-dju378
Main Authors: Kaye, Frederic J, Ivey, Alison M, Drane, Walter E, Mendenhall, William M, Allan, Robert W
Format: Article
Language:English
Subjects:
Adult
African Americans - statistics & numerical data
Ameloblastoma - diagnostic imaging
Ameloblastoma - drug therapy
Ameloblastoma - genetics
Ameloblastoma - pathology
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Compassionate Use Trials
Glutamic Acid
Humans
Imidazoles - administration & dosage
Imidazoles - adverse effects
Lung Neoplasms - drug therapy
Lung Neoplasms - secondary
Male
Mandibular Neoplasms - diagnostic imaging
Mandibular Neoplasms - drug therapy
Mandibular Neoplasms - genetics
Mandibular Neoplasms - pathology
Molecular Targeted Therapy - methods
Mutation
Neoplasm Recurrence, Local - diagnostic imaging
Neoplasm Recurrence, Local - drug therapy
Neoplasm Staging
Oximes - administration & dosage
Oximes - adverse effects
Proto-Oncogene Proteins B-raf - genetics
Pyridones - administration & dosage
Pyridones - adverse effects
Pyrimidinones - administration & dosage
Pyrimidinones - adverse effects
Radiography
Treatment Outcome
Valine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/dju378